journal
Journals Cardiovascular Revascularizati...

Cardiovascular Revascularization Medicine : Including Molecular Interventions

https://read.qxmd.com/read/38631937/2023-acc-aha-chronic-coronary-disease-guideline-an-opportunity-to-reestablish-coronary-artery-bypass-recommendations
#21
JOURNAL ARTICLE
Adnaldo da Silveira Maia, Magaly Arrais Dos Santos
Coronary artery bypass (CABG) has evolved over the decades, supported by scientific evidence from robust studies. The downgrade of the recommendation for CABG in patients with multivessel coronary artery disease proposed by the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization and the 2023 ACC/AHA Chronic Coronary Disease Guidelines has brought this discussion to the fore, with prestigious cardiothoracic surgery societies such as AATS and STS not supporting these recommendations. The purpose of this article is to broaden this discussion in light of published studies...
April 16, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38677895/frequency-of-ventriculography-during-left-heart-catheterization-for-radial-vs-femoral-access
#22
LETTER
Ilan Merdler, Brian C Case, Matteo Cellamare, Sukhdeep Bhogal, Pavan K Reddy, Cheng Zhang, Itsik Ben-Dor, Ron Waksman
BACKGROUND: Radial artery access has been used for left heart catheterization (LHC) and percutaneous coronary intervention (PCI) for over 30 years. This method has gained popularity among operators due to superficial vessel anatomy, allowing for easy accessibility and compressibility, resulting in effective hemostasis. METHODS: We conducted a retrospective analysis of patients who underwent PCI due to ST-elevation myocardial infarction (STEMI), non-ST-elevation acute coronary syndrome (NSTE-ACS), and chest pain (stable angina) from November 2013 to February 2023...
April 15, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38641439/how-much-does-cmd-cost-before-it-is-diagnosed
#23
EDITORIAL
Arnold H Seto, David M Tehrani
No abstract text is available yet for this article.
April 15, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38616461/emerging-trends-in-nationwide-mortality-limb-loss-and-resource-utilization-for-critical-limb-ischemia-in-young-adults
#24
JOURNAL ARTICLE
Fidelis Uwumiro, Victory Okpujie, Chikodili Nebuwa, Uwakmfonabasi Umoudoh, Evaristus Asobara, Emmanuel Aniaku, Golibe Makata, John Olukorode
BACKGROUND/OBJECTIVES: Recent trends indicate a rise in the incidence of critical limb ischemia (CLI) among younger adults. This study examines trends in CLI hospitalization and outcomes among young adults with peripheral arterial disease (PAD) in the United States. METHODS: Adult hospitalizations (18-40 years) for PAD/CLI were analyzed from the 2016-2020 nationwide inpatient sample database using ICD-10 codes. Rates were reported per 1000 PAD or 100,000 cardiovascular disease admissions...
April 14, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38658269/impact-of-sex-on-myocardial-perfusion-following-percutaneous-coronary-intervention-of-chronic-total-coronary-occlusions
#25
JOURNAL ARTICLE
Yvemarie B O Somsen, Ruben W de Winter, Stefan P Schumacher, Anna van Veelen, Pepijn A van Diemen, Ruurt A Jukema, Roel Hoek, Wynand J Stuijfzand, Ibrahim Danad, Jos W R Twisk, Niels J Verouden, Yolande Appelman, Alexander Nap, Sebastiaan A Kleijn, José P Henriques, Paul Knaapen
OBJECTIVES: We sought to investigate the impact of sex on myocardial perfusion changes following chronic total coronary occlusion (CTO) percutaneous coronary intervention (PCI) as measured by [15 O]H2 O positron-emission tomography (PET) perfusion imaging. BACKGROUND: CTO PCI has been associated with an increase in myocardial perfusion, yet females are less likely to undergo revascularization. As such, data on the impact of sex on myocardial perfusion following CTO PCI is scarce...
April 13, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38724408/comparing-planned-versus-ad-hoc-coronary-microvascular-assessment-early-findings-from-the-coronary-microvascular-disease-registry
#26
JOURNAL ARTICLE
Ilan Merdler, Nadjat Bazarbashi, Giorgio A Medranda, Cheng Zhang, Sevket Tolga Ozturk, Vaishnavi Sawant, Itsik Ben-Dor, Ron Waksman, Hayder D Hashim, Brian C Case
BACKGROUND: Coronary microvascular dysfunction (CMD) is an etiology for angina with non-obstructive coronary disease. However, the initial adoption of CMD assessment, whether planned or conducted ad hoc, is limited. We characterize planned and ad hoc CMD assessments and highlight evolving trends of a CMD referral center. METHODS: We analyzed outpatient data from the Coronary Microvascular Disease Registry from 2021 to 2023. Patients were categorized into planned or ad hoc CMD assessment groups, and baseline characteristics, hospital stay, medications, and physiological measurements were compared...
April 12, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38616462/outcomes-in-patients-with-low-flow-very-low-gradient-aortic-stenosis-a-long-term-follow-up
#27
LETTER
Lakshay Chopra, Carlo Mannina, Hiroki Ueyama, Jacqueline Mirza, Joseph Maenza, Ankur Dalsania, Francesca R Prandi, Edgar Argulian, Samin Sharma, Annapoorna Kini, Stamatios Lerakis
No abstract text is available yet for this article.
April 12, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38616460/a-novel-proof-of-concept-radiofrequency-renal-denervation-strategy-to-improve-procedural-efficiency-12-month-results-from-the-spyral-dystal-pilot-study
#28
JOURNAL ARTICLE
Andrew S P Sharp, David E Kandzari, Raymond R Townsend, Kazuomi Kario, Felix Mahfoud, Michael A Weber, Roland E Schmieder, Konstantinos Tsioufis, Michael Böhm, James W Choi, Minglei Liu, Vanessa DeBruin, David P Lee
BACKGROUND: Catheter-based renal sympathetic denervation (RDN) reduced blood pressure (BP) in multiple randomized sham-controlled trials of patients with uncontrolled hypertension (HTN). We tested proof-of-concept for a more selective treatment strategy, exclusively targeting these areas to improve the efficiency of the procedure. METHODS: The SPYRAL DYSTAL Pilot study was designed to mirror the SPYRAL HTN-OFF MED Pivotal study, enabling comparison with a propensity score adjusted active-control group...
April 10, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38729913/percutaneous-intervention-of-a-giant-saphenous-venous-coronary-graft-aneurysm-in-an-octogenarian-with-stemi
#29
Abhishek Chaturvedi, Kalyan R Chitturi, Waiel Abusnina, Ron Waksman, Nelson L Bernardo
No abstract text is available yet for this article.
April 8, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38599918/use-and-performance-of-the-evolut-fx-transcatheter-aortic-valve-system
#30
JOURNAL ARTICLE
Tanvir Bajwa, Guilherme F Attizzani, Hemal Gada, Stanley J Chetcuti, Mathew R Williams, Mustafa Ahmed, George A Petrossian, Matthew D Saybolt, Suhail Q Allaqaband, William M Merhi, Robert C Stoler, Hiram Bezerra, Paul Mahoney, Willis Wu, Robert Jumper, Larry Lambrecht, Gilbert H L Tang
BACKGROUND: The next generation supra-annular, self-expanding Evolut FX transcatheter aortic valve (TAV) system was designed to improve catheter deliverability, provide stable and symmetric valve deployment, and assess commissural alignment during the procedure. The impact of these modifications has not been clinically evaluated. METHODS: Procedural information was collected by survey in 2 Stages: Stage I comprised 23 centers with extensive experience with Evolut TAV systems, and Stage II comprised an additional 46 centers with a broad range of balloon- and self-expanding system experience...
April 7, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38664133/editorial-is-the-axiom-of-balloon-angioplasty-the-more-you-gain-the-more-you-lose-still-true-in-the-era-of-dcb-with-paclitaxel
#31
EDITORIAL
Patrick W Serruys, Akihiro Tobe, Kai Ninomiya, Scot Garg, Aloke V Finn, Bruno Scheller, Bernardo Cortese, Antonio Colombo, Bernhard Reimers, Sandeep Basavarajaiah, Faisal Sharif, Simone Fezzi, Chao Gao, Ling Tao, Yoshinobu Onuma
Balloon angioplasty achieves luminal enlargement by fracturing the atherosclerotic intima at its point of least resistance, thereby creating a dissection plane and space with dehiscence of the intima from the media. This barotraumatic dissection triggers an inflammatory and proliferative reaction, resulting in a restenosis process at medium-term. In the era of plain old balloon angioplasty, quantitative angiographic studies at follow-up demonstrated that - the greater the acute luminal gain was after balloon angioplasty, the greater the late luminal loss was at follow-up...
April 6, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38604832/prevalence-and-progression-of-lv-dysfunction-and-dyssynchrony-in-patients-with-new-onset-lbbb-post-tavr
#32
JOURNAL ARTICLE
Andrei D Margulescu, Dewi E Thomas, Magid Awadalla, Parin Shah, Ayush Khurana, Omar Aldalati, Daniel R Obaid, Alexander J Chase, David Smith
BACKGROUND: The impact of new-onset left bundle branch block (N-LBBB) developing after Transcatheter Aortic Valve Replacement (TAVR) on cardiac function and mechanical dyssynchrony is not well defined. METHODS: We retrospectively screened all patients who underwent TAVR in our centre between Oct 2018 and Sept 2021 (n = 409). We identified 38 patients with N-LBBB post-operatively (of which 28 were persistent and 10 were transient), and 17 patients with chronic pre-existent LBBB (C-LBBB)...
April 5, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38594158/geographical-and-socioeconomic-disparities-in-post-transcatheter-aortic-valve-replacement-pacemaker-placement
#33
REVIEW
Bilal Hussain, Sanchit Duhan, Ahmed Mahmood, Luay Al-Alawi, Mian Muhammad Salman Aslam, Christel Cuevas, Thomas Alexander, Mohammad M Ansari, Fahad Waqar
INTRODUCTION: Pacemaker (PPM) implantation is indicated for conduction abnormalities which can develop post-transcatheter aortic valve replacement (TAVR). However, whether post-TAVR PPM risk is associated with the geographical location of the hospital and socioeconomic status of the patient is not well established. Our goal was to explore geographical and socioeconomic disparities in post-TAVR PPM implantation. METHODS: A retrospective cohort analysis was conducted using the National Inpatient Sample 2016-2020 with respective ICD-10 codes for TAVR and PPM implantation...
April 5, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38664130/navigating-the-evolving-landscape-of-hfpef-management-a-detailed-look-at-key-acc-aha-esc-guideline-updates
#34
REVIEW
Niyati Grewal, Jaspreet Singh Grewal, Mohammed Aldhaeefi, Prafulla P Mehrotra, Urooj Fatima
Heart failure, a growing concern in the United States, significantly impacts both morbidity and mortality. Classified by ejection fraction, heart failure with preserved ejection fraction (HFpEF) now accounts for half of all cases and is steadily rising. Unlike its counterpart, heart failure with reduced ejection fraction (HFrEF), HFpEF lacks clear management guidelines. Recognizing this critical gap, we aim to review existing recommendations and formulate effective management strategies for HFpEF.
April 4, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38653674/cerebral-embolic-protection-device-utilization-and-outcomes-in-transcatheter-aortic-valve-replacement-a-nationally-representative-propensity-matched-analysis
#35
LETTER
Ahmed M Altibi, Laith Alhuneafat, Ahmad Jabri, Ahmad Al-Abdouh, Fares Ghanem
INTRODUCTION: In patients undergoing transcatheter aortic valve replacement (TAVR), cerebral embolic protection devices (CEPD) are used to possibly diminish the risk of periprocedural stroke. Trends and outcomes of CEPD usage in TAVR are not well characterized. METHODS: National readmission databases (NRD) 2017-2019 was used to identify hospital admissions for TAVR using ICD-10 codes, with versus without Sentinel CEPD. Primary outcomes of the study were in-hospital and 30-day stroke...
April 4, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38604833/the-percutaneous-reformation-and-sausage
#36
EDITORIAL
Spencer B King
No abstract text is available yet for this article.
April 4, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38594159/transcarotid-versus-transfemoral-transcatheter-aortic-valve-replacement-a-systematic-review-and-meta-analysis
#37
JOURNAL ARTICLE
Cyrus Munguti, Paul M Ndunda, Abdullah Abukar, Mohammed Abdel Jawad, Mohinder R Vindhyal, Zaher Fanari
BACKGROUND: In the 2021 Transcatheter Valve Therapy (TVT) registry, 8.9 % of patients underwent TAVR via access sites other than the femoral artery. Transthoracic approaches may be contraindicated in some patients and may be associated with poorer outcomes. Therefore other alternative access routes are increasingly being performed. We conducted a systematic review of the literature on transcarotid transcatheter aortic valve replacement (TC-TAVR) and meta-analysis comparing outcomes of TC-TAVR and other access routes...
April 4, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38584083/outcomes-of-mitral-valve-transcatheter-edge-to-edge-repair-for-patients-with-hemodynamic-instability-a-systematic-review-and-meta-analysis
#38
JOURNAL ARTICLE
Hiroaki Yokoyama, Tatsuya Kokawa, Saori Shigekiyo, Akiho Seno, Tomoko Izumi, Riyo Ogura, Keitaro Mahara, Shinobu Hosokawa
BACKGROUND: The outcomes after mitral valve transcatheter edge-to-edge repair (M-TEER) for the patients with severe mitral regurgitation (MR) in hemodynamically unstable conditions, such as cardiogenic shock, still remain unclear. We aimed to integrate previous publications regarding M-TEER indicated for life-threatening conditions and indirectly particularly compared the short-term outcomes thereof, with that of other treatments. METHODS: We systematically searched the PubMed, Cochrane, and MEDLINE databases for studies from inception to June 2023, regarding M-TEER in patients with hemodynamic instability and severe MR...
April 4, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38584082/temporal-trends-in-outcomes-following-inpatient-transcatheter-aortic-valve-replacement
#39
JOURNAL ARTICLE
Steven Imburgio, Sara Hazaveh, Lauren Klei, Anne Marie Arcidiacono, Shuvendu Sen, John Messenger, Robert Pyo, Daniel Kiss, Matthew Saybolt, Sameer Jamal, Brett Sealove, Joseph Heaton
INTRODUCTION: Despite the growing adoption of transcatheter aortic valve replacement (TAVR), there remains a lack of clinical data evaluating procedural safety and discharge practices. AIMS: This study aims to investigate if there have been improvements in postoperative clinical outcomes following TAVR. METHODS: In this large-scale, retrospective cohort study, patients who underwent TAVR as an inpatient were identified from 2016 to 2020 using the National Readmissions Database...
April 4, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38575448/coronary-obstruction-during-tavi-procedure-when-calcification-distribution-matters
#40
Donato Antonio Paglianiti, Marco Busco, Luca Bettari, Michele Bellamoli, Esther Campopiano, Mattia Basile, Diego Maffeo, Andrea Buono
No abstract text is available yet for this article.
April 2, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
journal
journal
40959
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.